Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 42 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Recently, dementia research has primarily concentrated on using Magnetic Resonance Imaging (MRI) to develop learning models in processing and analyzing brain data. However, these models often cannot provide early detection of affected brain regions. Alternatively, mental test scores such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) offer valuable insights into the likelihood of dementia and cognitive impairments. The main objective of this study is to introduce an innovative and dependable context-aware health monitoring system based on fog computing to measure mental impairment in the elderly population. The framework provides screening tests utilizing MMSE and MoCA to achieve accurate and real-time monitoring of cognitive function, allowing for early detection and treatment of mental disorders. To assess the effectiveness of our screening test, we evaluated a dataset comprising 450 subjects with Mild Cognitive Impairment (MCI) from Kaferelshikh University. The aggregated dataset is categorized into three classes: (1) 150 patients with MCI, (2) 150 subjects with subcortical diseases, Parkinson's Disease (PD), and (3) 150 subjects with cortical diseases, Alzheimer's Disease (AD). To accurately determine health risks, we employ an ensemble AdaBoost model, providing superior performance in accuracy, precision, recall, F-score, and Area Under the Curve (AUC). To validate the effectiveness of our Machine Learning (ML) model on unseen data, we evaluate an additional 18 subjects using the proposed scoring test, with six subjects from each class. The results indicate that our proposed ML model achieves an impressive accuracy of 0.93, outperforming the MoCA score (0.90) and MMSE score (0.83). Through our research, we demonstrate the potential of our context-aware fog computing approach in significantly enhancing early diagnosis of dementia, leveraging mental test scores as valuable indicators.

Key findings

Why it matters

This study developed a fog computing-based system using MMSE and MoCA mental test scores with an AdaBoost model, reporting 0.93 accuracy for predicting dementia progression. It is a screening and prediction tool and does not test any treatment, cure or prevention.

Study details

How this study scored 42/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 42 of 100.42 of 100 points earned58 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 450 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 2.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Nora Mahmoud El-Rashidy: h-index 26 (OpenAlex, whole career)
Institution's track record 0 / 3 Kafrelsheikh University: institution h-index 211 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40670451)
Free to read 2 / 2 Free to read
Total 42 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Ali, Z. H., Hassan, E., Elgamal, S., & El-Rashidy, N. M. (2025). Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression. Scientific Reports. https://doi.org/10.1038/s41598-025-06310-4

Vancouver

Ali ZH, Hassan E, Elgamal S, El-Rashidy NM. Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression. Scientific Reports. 2025. doi:10.1038/s41598-025-06310-4. PMID: 40670451.

BibTeX

@article{ali2025-40670451,
  author  = {Ali, Zainab Hassan and Hassan, Esraa and Elgamal, Shimaa and El-Rashidy, Nora Mahmoud},
  title   = {{Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-06310-4},
  pmid    = {40670451},
  url     = {https://doi.org/10.1038/s41598-025-06310-4}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →